La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Delivra Health Brands Salute del bilancio

Salute finanziaria criteri di controllo 4/6

Delivra Health Brands ha un patrimonio netto totale di CA$3.6M e un debito totale di CA$2.0M, che porta il suo rapporto debito/patrimonio netto a 55.4%. Le sue attività totali e le sue passività totali sono rispettivamente CA$9.3M e CA$5.8M.

Informazioni chiave

55.4%

Rapporto debito/patrimonio netto

CA$1.97m

Debito

Indice di copertura degli interessi	n/a
Contanti	CA$3.40m
Patrimonio netto	CA$3.56m
Totale passività	CA$5.76m
Totale attività	CA$9.31m

Aggiornamenti recenti sulla salute finanziaria

Health Check: How Prudently Does Harvest One Cannabis (CVE:HVT) Use Debt?

May 29

Recent updates

Health Check: How Prudently Does Harvest One Cannabis (CVE:HVT) Use Debt?

May 29

Did The Underlying Business Drive Harvest One Cannabis' (CVE:HVT) Lovely 345% Share Price Gain?

Feb 11

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( CA$7.7M ) di DHB superano le sue passività a breve termine ( CA$4.0M ).

Passività a lungo termine: Le attività a breve termine di DHB ( CA$7.7M ) superano le sue passività a lungo termine ( CA$1.7M ).

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: DHB ha più liquidità del suo debito totale.

Riduzione del debito: Il rapporto debito/patrimonio netto di DHB è aumentato da 0% a 55.4% negli ultimi 5 anni.

Bilancio

Analisi della pista di contanti

Per le società che in passato sono state mediamente in perdita, valutiamo se hanno almeno un anno di liquidità.

Pista di liquidità stabile: DHB ha una cash runway sufficiente per più di 3 anni in base al suo attuale free cash flow.

Previsione Cash Runway: Dati insufficienti per determinare se DHB ha una sufficiente pista di cassa se il suo flusso di cassa libero continua a crescere o a ridursi in base ai tassi storici.

Delivra Health Brands Salute del bilancio

Salute finanziaria criteri di controllo 4/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

Health Check: How Prudently Does Harvest One Cannabis (CVE:HVT) Use Debt?

Recent updates

New minor risk - Profitability

Third quarter 2024 earnings released: CA$0.001 loss per share (vs CA$0.003 loss in 3Q 2023)

Second quarter 2024 earnings released: CA$0.002 loss per share (vs CA$0.004 profit in 2Q 2023)

Delivra Health Brands Inc., Annual General Meeting, Apr 29, 2024

New minor risk - Shareholder dilution

Delivra Health Brands Inc. announced that it has received CAD 0.9 million in funding

Delivra Health Brands Inc. announced that it expects to receive CAD 0.9 million in funding

Delivra Health Brands Inc. announced that it expects to receive CAD 0.9 million in funding

First quarter 2024 earnings released: EPS: CA$0.001 (vs CA$0.002 loss in 1Q 2023)

Insufficient new directors

Full year 2023 earnings released: CA$0.001 loss per share (vs CA$0.028 loss in FY 2022)

Delivra Health Brands Inc. to Report Fiscal Year 2023 Results on Oct 18, 2023

Third quarter 2023 earnings released: CA$0.003 loss per share (vs CA$0.007 loss in 3Q 2022)

Delivra Health Brands Inc. to Report Q3, 2023 Results on May 23, 2023

Second quarter 2023 earnings released: EPS: CA$0.004 (vs CA$0.006 loss in 2Q 2022)

First quarter 2023 earnings released: CA$0.002 loss per share (vs CA$0.006 loss in 1Q 2022)

Full year 2022 earnings released: CA$0.028 loss per share (vs CA$0.09 loss in FY 2021)

Delivra Health Brands Inc. to Report Fiscal Year 2022 Results on Oct 28, 2022

Third quarter 2022 earnings released: CA$0.007 loss per share (vs CA$0.005 loss in 3Q 2021)

Harvest One Cannabis Inc. Provides Earnings Guidance for the Fourth Quarter of 2022

Second quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

Harvest One Continues to Expand its Licensed LivRelief InfusedTM Product Line with the Listing of Extra Strength Transdermal CBD Cream at the OCS

First quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

Full year 2021 earnings released: CA$0.13 loss per share (vs CA$0.28 loss in FY 2020)

Health Check: How Prudently Does Harvest One Cannabis (CVE:HVT) Use Debt?

Third quarter 2021 earnings released: CA$0.005 loss per share (vs CA$0.17 loss in 3Q 2020)

Harvest One Cannabis Inc. Announces the Launch of Its New LivRelief

Harvest One Cannabis Inc. has completed a Composite Units Offering in the amount of CAD 4.99999 million.

Cann Group Limited (ASX:CAN) completed the acquisition of Satipharm Ltd, Satipharm AG and Phytotech Therapeutics Ltd from Harvest One Cannabis Inc. (TSXV:HVT)

Second quarter 2021 earnings released

Cann Group Limited (ASX:CAN) entered into a definitive sale agreement to acquire Phytotech Therapeutics Ltd from Harvest One Cannabis Inc. (TSXV:HVT).

Cann Group Limited (ASX:CAN) signed a share sale agreement to acquire Satipharm Ltd from Harvest One Cannabis Inc. (TSXV:HVT) for CAD 4 million.

Harvest One Continues International Expansion with Asian Distribution Agreement for Dream Water Products

Did The Underlying Business Drive Harvest One Cannabis' (CVE:HVT) Lovely 345% Share Price Gain?

New 90-day high: CA$0.24

Harvest One Cannabis Inc. Expands Distribution of Dream Water Products in the United States and Internationally

Harvest One Cannabis Inc. Announces Executive Changes

Full year earnings released - CA$0.29 loss per share

An unknown buyer acquired a majority stake in Greenbelt Greenhouse Ltd from Harvest One Cannabis Inc. (TSXV:HVT) for approximately CAD 2.9 million.

Harvest One Cannabis Inc. Announces Management Changes

Analisi della posizione finanziaria

Storia e analisi del rapporto debito/patrimonio netto

Bilancio

Analisi della pista di contanti

Scoprire le aziende sane